Genmab Cash Flow from Investing Activities 2010-2025 | GNMSF
Genmab cash flow from investing activities for the twelve months ending March 31, 2025 was $-4.426B, a 461.07% increase year-over-year.
- Genmab annual cash flow from investing activities for 2024 was $-1.437B, a 671.71% increase from 2023.
- Genmab annual cash flow from investing activities for 2023 was $-0.186B, a 52.39% decline from 2022.
- Genmab annual cash flow from investing activities for 2022 was $-0.391B, a 155.7% increase from 2021.